FDA Approved: FIRAZYR — Original Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

The FDA approved Firazyr (icatibant acetate) from Takeda Pharmaceuticals America, Inc. for the acute treatment of hereditary angioedema attacks.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• Firazyr (icatibant)

Snippet

ORIG AP for FIRAZYR (ICATIBANT ACETATE)